US BANCORP \DE\ - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$312,000
+44.4%
1,814
+5.0%
0.00%
Q2 2021$216,000
-10.0%
1,727
-2.2%
0.00%
Q1 2021$240,000
+10.1%
1,765
+3.4%
0.00%
Q4 2020$218,000
+14.7%
1,707
+1.1%
0.00%
Q3 2020$190,000
+123.5%
1,689
+90.4%
0.00%
Q2 2020$85,000
+8400.0%
887
+4568.4%
0.00%
Q4 2019$1,0000.0%190.0%0.00%
Q3 2019$1,000
-66.7%
19
-73.6%
0.00%
Q1 2019$3,000
-87.5%
72
-85.6%
0.00%
Q2 2018$24,000
+20.0%
5000.0%0.00%
Q1 2018$20,0005000.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Polaris Venture Management Co IV LLC 1,480,060$53,563,00085.86%
NEXTHERA CAPITAL LP 217,817$7,883,0004.84%
Novo Holdings A/S 903,833$32,710,0002.90%
SECTORAL ASSET MANAGEMENT INC 481,765$17,435,0001.71%
Perceptive Advisors 589,890$21,348,0001.38%
RA Capital Management 318,565$11,529,0001.19%
OAK RIDGE INVESTMENTS LLC 1,226,468$44,386,0001.15%
Granahan Investment Management 817,149$29,573,0000.97%
Eventide Asset Management 428,900$15,522,0000.95%
QVT Financial LP 636,764$23,044,0000.87%
View complete list of ACCELERON PHARMA INC shareholders